© 2019 by HemaDycamics

MARKET

Business Model

Patient Identifiers/FMs
HemaFlow Imager

Reusable

Consumable

Bio-Tech Companies

Royalties    IP Rights
Direct​
Indirect
Physicians
University Researchers
Clinical Researchers
Patients
Distributors

Product

Channels

Customers

Users

Regulatory Pathway

Our device strategy aims to go towards a FDA 510(k) Class II exemption.

Prepare Documentation

Submit 510K FDA Clearance 

Apply for

Class II

Financial Projections

HemaFlow Imager


$5000              $30000               6x

 COGS                Price            Mark-up

Patient Identifiers

$0.10                $5.00                50x

Intellectual Property

Motion Stabilized Flow

Imaging Device

US Patent Application

No.: 62/804,471

Competition